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BTV-8eak of bluetongue ever recorded in northern Europe started in Belgium and the
Netherlands, spreading to Luxemburg, Germany and north-east France. The virus overwintered (2006–2007)
reappearing during May–June 2007 with greatly increased severity in affected areas, spreading further into
Germany and France, reaching Denmark, Switzerland, the Czech Republic and the UK. Infected animals were
also imported into Poland, Italy, Spain and the UK. An initial isolate from the Netherlands (NET2006/04) was
identiﬁed as BTV-8 by RT-PCR assays targeting genome segment 2. The full genome of NET2006/04 was
sequenced and compared to selected European isolates, South African vaccine strains and other BTV-8
strains, indicating that it originated in sub-Saharan Africa. Although NET2006/04 showed high levels of
nucleotide identity with other ‘western’ BTV strains, it represents a new introduction and was not derived
from the BTV-8 vaccine, although its route of entry into Europe has not been established.
© 2008 Elsevier Inc. All rights reserved.Introduction‘Bluetongue’ (BT) is an economically important disease affecting
sheep (with case fatality rates that can occasionally exceed 70%
Gambles, 1949), some species of deer and to a lesser extent cattle and
goats. The bluetongue virus (BTV) is transmitted almost exclusively by
adult female hematophagous midges, belonging to certain species of
the genus Culicoides, and can infect most ruminant or camelid species.
BT in sheep is characterised by a loss of condition, muscle degenera-
tion, coronitis, haemorrhages, respiratory distress and swelling of the
head and neck, which occasionally leads to cyanosis of the tongue
(after which the disease is named). Clinical signs of BT can be parti-
cularly severe in naive sheep populations (in areas that are normallyrtens).
l rights reserved.free of the disease), or after introduction of an exotic strain into
endemic areas (Darpel et al., 2007; MacLachlan 2004; Prasad et al.,
in press).
A series of BT outbreaks that started in 1998 has spread across
much of southern and central Europe, involving eight different virus
strains, belonging to ﬁve distinct serotypes (BTV-1, 2, 4, 9 and 16).
These viruses arrived in Europe via three distinct routes: from the east
through Turkey into Greece and Bulgaria; from Algeria or Tunisia into
Italy and the eastern Mediterranean islands, or via Morocco into the
Iberian Peninsula (Mellor andWittmann, 2002; Mertens et al., 2007b).
The arrival of multiple BTV strains and their persistence in Europe
have been linked to the effects of climate change (particularly higher
temperatures) and its inﬂuence on both the distribution and vector
capacity of local Culicoides populations (Conte et al., 2003; Purse et al.,
2005; Purse and Rogers, in press).
The record temperatures experienced in northern Europe during
the summer of 2006 coincided with the ﬁrst outbreak of bluetongue
ever recorded in the region, spreading across theNetherlands, Belgium,
309S. Maan et al. / Virology 377 (2008) 308–318Luxemburg,much of Germanyand into north-east France (Darpel et al.,
2007; OIE, 2006a; Toussaint et al., 2006). During the ﬁrst year of the
outbreak morbidity and mortality levels were low, for example it is
estimated that Belgium lost less than 100 animals in total (Elbers et al.,
2007). However, the virus overwintered successfully (2006–2007)
reappearing in the same regions during May–June 2007, then spread-
ing further across Central France and Germany, arriving in Denmark
and the East Anglian region of the UK during September/October 2007,
then into Switzerland and the Czech Republic. Most signiﬁcantly the
incidence and severity of the disease dramatically increased in the
second year with case fatality levels in sheep approaching 50% in some
areas. During the late summer it was estimated that Belgium alone lost
N15% of its entire sheep population killed by the disease. There were
reports of reduced productivity, loss of milk yield, and low levels of
mortality in cattle (b1%), as well as clear indications of vertical trans-
mission (particularly in cattle— Zentis, 2008), and abortion/sterility in
both cattle and sheep (Hoogendam, 2007; Wilson and Mellor, 2007).
Movement of cattlewithin Europe resulted in the importation of BTV-8
infected animals and outbreaks in Spain and Italy in 2007–2008. Small
numbers of infected animals were also imported into Poland, Romania
and the UK (including England, Scotland and Northern Ireland). At the
end of 2007 this was already the largest and most economically
damaging outbreak caused by a single BTV strain on record. Although
there are some plans for mass vaccination, it appears likely that the
outbreakwill continue to spread and increase in intensity during 2008,
particularly in newly affected areas.
Bluetongue virus is the type species of the genus Orbivirus within
the family Reoviridae (Mertens et al., 2005). The virus genome is
composed of ten segments of linear double stranded RNA (Verwoerd,
1970), which code for ten distinct viral proteins (Mertens et al., 1984,
1987a,b, 2007c). The inner layers forming the ‘core’ of the BTV capsid
contain VP1, VP3, VP4, VP6 and VP7 (encoded by genome segment
(Seg) 1, 3, 4, 9 and 7 respectively). These core proteins and two of the
non-structural proteins (NS1 and NS2: encoded by Seg-5 and 8 re-
spectively) are thought to be relatively conserved, and are antigeni-
cally cross-reactive between different strains and serotypes of BTV.
However, cross-hybridisation and sequencing studies have shown that
these genome segments can vary in a manner that reﬂects the geo-
graphic origin of the virus strain (topotype) (Gould and Pritchard,
1990; Mertens et al., 1987b; Pritchard et al., 1995, 2004).
Genome segment 10 (encoding non-structural proteins NS3/N3a of
BTV) is more variable than the majority of the genome segments en-
coding the other non-structural or core proteins. The signiﬁcance of
variations in NS3/NS3a is not fully understood, although it is clear that
these non-structural proteins do not determine virus serotype. It has
been suggested that variations in Seg-10might relate to transmission of
the virus by different insect vector populations and species (Balasuriya
et al., 2008; Bonneau et al., 1999; Nikolakaki et al., 2005; Wilson et al.,
2007). Seg-7 of BTV, encoding the outer core protein VP7, also shows
signiﬁcant variations (Wilson et al., 2000), despite the role of VP7 as the
major serogroup-speciﬁc antigen. It has been suggested that these
variations could also relate to the insect populations that act as vectors
for different virus strains in different geographic areas (Bonneau et al.,
2000; Wilson et al., 2000).
The BTV outer capsid proteins VP2 and VP5 (encoded by Seg-2 and
Seg-6 respectively) determine the speciﬁcity of interactions between
the virus particle and the neutralising antibodies generated during
infection of themammalian host (Cowley andGorman,1989; Huismans
et al., 1985; Mertens et al., 1989). Genome segments 2 and 6 show high
levels of sequence variation that correlate with virus serotype (parti-
cularly in VP2/segment 2 — Maan et al., 2007a; Mertens et al., 2007g;
Singh et al., 2004). However, these genome segments also show var-
iationswithin each serotype that correlatewith the geographic origin of
the virus strain (Seg-2 and 6 ‘topotypes’) (Bonneau et al., 1999; Gould
and Pritchard 1990; Maan et al., 2007a; Mertens et al., 2007g; Singh
et al., 2004; Zhang et al., 1999).Bluetongue virus was isolated from the blood of sheep showing
severe clinical signs of disease in the Netherlands during August 2006
(IAH reference collection number NET2006/04). We report the ﬁrst
identiﬁcation of this virus as BTV-8, the cause of the northern Euro-
pean BT outbreak in 2006. We also report the complete nucleotide
sequence of the virus genome, and a comparison of each genome
segment to other European ﬁeld strains, and the BTV vaccine strains
that have been used in the region. Comparisons were also made to
representative ‘eastern’ and ‘western’ bluetongue viruses from other
parts of the world (including other strains of BTV-8), in an attempt to
clarify the origins of the outbreak virus.
Results
Virus isolation and propagation in cell culture
Blood samples from sheep showing clinical signs of bluetongue
(sample number A83/06-6) were sent from the Netherlands to the
CommunityReference Laboratory (CRL) at IAHPirbright. Initial attempts
to isolate virus directly into BHK-21 cells failed, even though the
sample was positive by ELISA and real-time RT-PCR. No virus (or CPE)
was detected when material passaged in embryonated chicken eggs
(BTV8-E1) was titrated on BHK cells, although BTV8-E1 was positive
for BTV RNA by real-time RT-PCR (CT 18.05). However, supernatant
from Culicoides sonorensis cell cultures (KC cells), 7 days after ino-
culationwith RBC from sample number A83/06-6, did cause 100% CPE
in BHK-21 cells at 4 days post infection. This virus isolate was added
to the IAH reference collection as NET2006/04 — (passage level KC1/
BHK1 —Mertens et al., 2007d).
Identiﬁcation and typing of NET2006/04
The northern European virus was identiﬁed as BTV by RT-PCR
assays targeting Seg-7 (Anthony et al., 2007), generating an amplicon
of the expected size (1156 bp) from EDTA treated blood samples,
infected egg material and infected cell-culture supernatants (Fig. 1—
Panel D). Real-time RT-PCR assays targeting Seg-1 (Shaw et al., 2007)
conﬁrmed this result and showed that the virus belongs to a ‘western’
lineage, indicating that it originated from Africa or America.
Serotype speciﬁc RT-PCR assays targeting Seg-2 only generated
amplicons of the expected size with the primers for BTV-8 (Mertens
et al., 2007b, and in preparation) excluding the other 23 BTV serotypes
(Fig. 1—Panels A–C). This represents the ﬁrst positive identiﬁcation of
BTV-8 in Europe and was conﬁrmed using multiple additional primer
pairs and sequencing of Seg-2. Sequence comparisons with Seg-2
of reference strains for the 24 BTV serotypes (Maan et al., 2007a),
showed 93.4% nt sequence identity with the BTV-8 reference strain
(RSArrrr/08).
Full-length sequence analyses and comparison of theNET2006/04 genome
Genome segments 1 to 10 of NET2006/04 range in size from 3944
(Seg-1) to 822 base pairs (bp) (Seg-10), encoding proteins from 1302
(VP1) to 229/216 amino acids (aa) (NS3/NS3A) respectively. Details of
individual genome segments are given in Table 1.
Genome segment 1 of BTV-8NET2006/04was compared to available
data for other ‘western’ viruses, and to BTV-2 from Taiwan (Table 1 —
supplementary data). In each case Seg-1 is 3944 bp long, encoding the
RNA polymerase protein (Pol) of 1302 aa. The 5′ non-coding regions
(NCR) is 11 bases long and is 100% conserved, while the 3′ NCR is 24
nucleotides (nt) long and is N91.6% conserved, for the BTV strains
analysed (Table 1). The full-length sequence of Seg-1 is also highly
‘conserved’, showing N78.7% identity overall, with NET2006/04 most
closely related (94.5% identity) to BTV-2 from Corsica 2002 (Ac. No.
AY154458). TheAfrican andAmerican isolates of BTV-2 (L20508); BTV-
10 (X12819); BTV-11 (L20445); BTV-13 (L20446); andBTV-17 (L20447)
Fig. 1. Electrophoretic analysis of cDNA products from Seg-2 and Seg-7 of BTV-8 NET2006/04 isolate using the type speciﬁc primer pairs against 24 BTV types and generic primers for
Seg-7. PCR amplicons were generated from cDNA of BTV-8 isolate NET2006/04 with three type 8 speciﬁc primer pairs (lane 8) (Mertens et al., 2007b) as indicated in panel A. No
ampliﬁcation was seen with primer pairs of other serotypes (Lanes 1 to 7 and 9-24-Panel A–C). Panel D showed the ampliﬁcation of BTV RNA with Seg-7 speciﬁc primers (Anthony
et al., 2007). Lane M: 1 kb marker.
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from the Netherlands (91% identity), but only 78.7–80.1% identity to
BTV-2 Taiwan (AY493686), indicating a clear separation into eastern
and western groups (Fig. 1 — supplementary data).
Genome segment 2 encodes VP2, the outermost component of the
virus capsid and the most variable of the BTV proteins (Maan et al.,
2007a). Although Seg-2 can vary in length between different BTV
types, it usually has a uniform length within each serotype, or Seg-2
nucleotype (Maanet al., 2007a). Seg-2of BTV-8 (includingNET2006/04)
is conserved at 2939 bp, encoding a protein of 961 aa (Table 1). It has
upstream and downstream NCRs of 17 bp and 36 bp, which show 100%
and 97.2% identity respectively to Seg-2 NCRs of the other BTV-8 strains
analyzed.
The full-length sequence of Seg-2 from NET2006/04 did not group
closely with any of the other European strains analysed (Fig. 2A). It
clustered closelywith the reference strain of BTV-8 (93.4% nt identity),
conﬁrming its initial identiﬁcation by RT-PCR. In contrast it showed
only 45% to 71.1% nt identity to reference strains of the other 23 BTV
serotypes. NET2006/04 showed some similarity to reference strains of
BTV-18 (71.1%) and BTV-23 (69.8%), which have previously been
grouped with BTV-8 within ‘Seg-2, nucleotype D’ (Maan et al., 2007a).
Seg-2 of the different BTV-8 isolates analysed showed92.4–99.9%nt
identity to the BTV-8 reference strain (RSArrrr/08). Seg-2 of the BTV-8
vaccine strain had only 9 nt differences from RSArrrr/08 (99.7% nt
identity) from which it was derived (isolated in South Africa in 1937:
reviewed by Alpar et al., in press). Although Seg-2 of BTV types 1, 2, 9
and 16 all showed evidence for separation into east–west topotypes,
within each serotype (Fig. 2A), the BTV-4 and8 strains analyzedwere all
from western origins; consequently there was no evidence for sepa-
ration of Seg-2 into eastern and western groups within these two
serotypes.NET2006/04wasmost closely related (97% identity) to BTV-8
from Nigeria (NIG1982/07) but showed less similarity (93.4%) to the
BTV-8 vaccine strain, indicating a more distant relationship. The recent
SouthAfrican isolates of BTV-8 (RSA1998/01, RSA1992/01 andRSA1987/
01) are closely related to each other, with 97.8% to 99.6% nt identity(based on ~1000 bp region at the downstream end of Seg-2). However,
they are more distantly related to NET2006/04 (94.1–94.7% nt identity)
and the earlier South African strains (92.4–93.6% nt identity— Figs. 2A
and B). Sequence data for Seg-2 of multiple northern European isolates
of BTV-8 (2006–2008) showed that they are all closely grouped with
NET2006/04 (N99.8% identity— including France (FRA2006/01) and the
UK (UKG2007/05)).
Genome segment 3 encodes the highly conserved BTV sub-core-shell
protein, VP3(T2). Seg-3 of the different European BTV strains is con-
served at 2772 nt, encoding 901 aa, with upstream and downstream
NCRs of 17 and 49 bases respectively (Table 1). Seg-3 of NET2006/04
showed N95% nt similarity to other ‘western’ group viruses, but only
80.9%–81.1% similarity to the ‘eastern’European isolates analysed,which
form a distinct cluster with N90.7% identity (Fig. 2 — supplementary
data).
Genome Segment 4 encodes the highly conserved BTV capping and
transmethylase enzyme—VP4(CaP). Seg-4was 1981nt long (regardless
of BTV strain) encoding 644 aa, with a fully conserved 8 bp upstream
NCR (Table 1). In contrast the 38 bp downstream NCR was more
variable, showing 97.3% identity between the western strains, which
show only 92% identity with BTV-2 from Taiwan (Table 1 —
supplementary data). The full-length nt sequence of Seg-4 from
NET2006/04 showed N78.6% nt identity to other BTV strains, grouping
it with the other ‘western’ isolates (which showed 88.8–99.7% nt
identity— Fig. 3— supplementary data). In contrast, BTV-2 from Taiwan
(Ac. No. AY493689) showed only 78.6 to 80.1% to the ‘western’ viruses.
The western group contained two subgroups, the larger of which
included prototype strains of serotype 10, 11, 13 and 17 from the USA.
NET2006/04 shows80.1%nt identity to BTV-2 Taiwan, and is included in
the 2nd subgroup (along with BTV-2 strains from the USA (Ac. No.
L08637), Corsica (Ac. No. AY129085) and South Africa (vaccine strain—
Ac. No. AY134477)), which shows a slightly closer relationship to BTV-2
Taiwan.Within this subgroupNET2006/04 ismost closely related to the
Corsican and South Africa (vaccine) strains (95.7% and 94.8% identity
respectively).
Table 1
Characteristics of dsRNA genome segments (cDNA copy) and proteins of the bluetongue virus serotype 8 Netherland (NET2006/04)
Pol=RNA polymerase; Cap=capping enzyme (guanylyltransferase); Hel=helicase enzyme [42]; T2=protein with T=2 symmetry; T13=Protein with T=13 symmetry; ViP=viral inclusion body matrix protein; TuP= tubule protein. Letters in bold blue are the 5′ and 3′
terminal conserved sequences in genome segments of BTV-8 NET2006/04. Letters in red are the substitution of C for A at sixth position from 3′ end in genome segment 1 in NET2006/06, and T for A in genome segment 9, in NET2006/06 and six other western viruses
(out of 41 strains analysed).
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Fig. 2. A: Neighbour-joining tree showing the relationships between nucleotide sequences of Seg-2 from European strains of BTV serotype 1, 2, 4, 8, 9 and 16. The treewas constructed
using distance matrices, generated using the p-distance determination algorithm in MEGA 3 (2000 bootstrap replicates) (Kumar et al., 2004). The numbers indicate bootstrap
conﬁdence values after 2000 replications. p indicates partial sequences. The trees shown in Figs. 2B–6 were drawn using same parameters. B: Neighbour-joining tree showing
relationships between nucleotide sequences of Seg-2 from strains of BTV-8.
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ﬁeld strains, and the South African BTV-vaccine strains (Table 1 and
Fig. 4 — supplementary data). Seg-5 of NET2006/04 is 1776 nt long,
encoding NS1(TuP) at 552 aa, with upstream and downstreamNCRs of
34 and 83 bp in length (Table 1). Seg-5 from the different BTV isolates
formed two distinct clusters, representing eastern and western line-
ages with 82.2–83.5% identity between members of these different
groups. The eastern group included European ﬁeld strains of BTV-1
(from Greece), 9 and 16, as well as the vaccine strain of BTV-16.
However, NET2006/04 clusters with the ‘western’ viruses, including
European ﬁeld strains of BTV-2 and 4, and the South African vaccine
strains of types 1, 2, 4 and 9.Seg-5 of NET2006/04wasmost closely related to BTV-4 fromGreece
(GRE1999/15 — 97.5% identity) providing the ﬁrst sequence data in-
dicating that the northern European outbreak in 2006 was caused by a
‘western’ virus. Within the eastern group, the Sardinian ﬁeld isolates of
BTV-16 (SAD2004/03 and SAD2004/04) were almost identical to the
BTV-16 SouthAfrican vaccine strain, with 99.9% nt similarity, indicating
a very recent common ancestry. Within the western group, European
ﬁeld strains of BTV-2 from Spain (SPA2005/01) and BTV-16 from Italy
(ITL2002 — Ac. No. DQ017960) were almost identical (99.9–100%) to
Seg-5 of the South African BTV-2 vaccine strain (RSAvvvv/02-Ac. No.
AM773684 and AY138895), indicating that a reassortment event has
taken place between vaccine strains from different serotypes.
313S. Maan et al. / Virology 377 (2008) 308–318Genome segment 6 encodes VP5— the smaller outer capsid compo-
nent and second most variable of the BTV proteins. Seg-6 of the
different BTV-8 isolates is 1637 bp long showing N94.7% nt identity,
and encoding 526 aa (Table 1). The upstream and downstream NCRs
are 27 and 29 bp long, with 96.2% and 100% identity respectively.
Comparisons of Seg-6 from the European strains of BTV-1, 2, 4, 8, 9 and
16, identiﬁed seven main lineages, which primarily correlate with
virus serotype (Fig. 3). However, the BTV-1 strains from the Medi-
terranean region included two distinct lineages, represented by an
eastern strain (GRE2001/01) and a western strain (ALG2006/01 and
MOR2006/06) (Fig. 3), reﬂecting two distinct Seg-6 topotypes and
introductions of BTV-1 from different geographic origins. The Seg-6
sequence of GRE2001/01 showed a relatively large separation (79%
similarity) from the BTV-1 vaccine strain (RSAvvvv/01), reﬂecting
their derivation from eastern and western groups of viruses respec-
tively. In contrast ALG2006/01 and MOR2006/06 showed 95% nt si-
milarity to the vaccine strain, reﬂecting a closer geographical origin.
Seg-6 from different BTV-9 isolates also formed two distinct
groups, containing ‘eastern’ strains from Europe 2000 to 2002, and the
‘western’ vaccine strain, respectively. However, these two groups are
much more widely separated (30.4% variation) in a manner similar to
Seg-6 from different BTV serotypes (Fig. 3). This not only indicates that
Seg-2/VP2 sequences (and not Seg-6/VP5) determine the identity of
BTV-9, but also that one or other of these lineages has acquired
segment 6 by reassortment with a distinct virus type.
Seg-6 of NET2006/04 grouped with other BTV-8 isolates from
Nigeria, Kenya and S. Africa (reference strain) with N94.8% similarity
overall. As already noted for Seg-2 (encoding VP2), the closest strain to
NET2006/04 was BTV-8 from Nigeria isolated during 1982 (NIG1982/
07), with 97.7% nt similarity.
Genome segment 7 of NET2006/04 is 1156 bp long, encoding the
349 aa of the major BTV serogroup-speciﬁc antigen and core surface
protein — VP7. The upstream and downstream NCRs are 17 and 89
bases long respectively (Table 1). The aa sequence of VP7 is signiﬁ-
cantly more conserved (N80.2% identity) than suggested by the nt
sequence of Seg-7 of NET2006/04 which shows 75.5%–97% nt identity
to the other BTV strains. This reﬂects large numbers of synonymous
mutations in the third base position.Fig. 3. Neighbour-joining tree showing relationships between nucleotide sequUnlike majority of the BTV genome segments, Seg-7 formed six
distinct clusters. Three of these are primarily from a western origin
(with the single exception of the Chinese strain of BTV-12) and three
from an eastern origin (Fig. 4). Two other Mediterranean BTV strains
(BTV-2 Tunisia — Ac. No. AF469115 and BTV-2 Corsica — Ac. No.
AY079124), belonging to western group 2) were included in these
comparisons, showing 79.3% and 80.1% identity with NET2006/04
respectively. Within western group 1, NET2006/04 clusters closely
(97% identity) with BTV-1 Honduras (Ac. No. AF188670) and the South
African BTV-1 reference strain (Ac. No. AF188669) (Fig. 4).
Genome segment 8 of BTV is conserved at 1125 bp, encoding the 354
aa of the viral inclusion body (VIB) matrix protein — NS2. The up-
stream and downstream NCRs (19 and 41 bp respectively) are fully
conserved in the viruses compared (Table 1). Seg-8 of the European
BTV isolates showed clear separation into eastern andwestern groups,
with NET2006/04, vaccine strains of BTV-2, 4 and 9 and European ﬁeld
strains of BTV-2 and 4, in the western group (Fig. 5). Overall nt
identities of 76.1% to 80.4% were detected between the eastern and
western groups. Preliminary sequence data for Seg-8 of BTV-1 from
Greece (GRE2001/01) and BTV-16 from Turkey (TUR2000/01) indicate
that they both group within the eastern cluster. Seg-8 of NET2006/04
showed 99.8% similarity to a distinct isolate from the same outbreak in
the Netherlands, but from a different animal (NET2006/01). It also
showed relatively high levels of nt similarity to the South African
vaccine strains of BTV-2 (Ac. No. AY138896 — 96.6%), BTV-4 (Ac. No.
AY857502 — 95.5%) and BTV-9 (RSArrr1/09 -Ac. No. AM900374 —
95.6%), as well as to the Corsican ﬁeld strains of BTV-4 (Ac. No.
AY857499 — 96%) and BTV-2 (Ac. No. AY124372 — 92.8%).
Genome segment 9 codes for minor core protein VP6, the core
associated helicase of BTV. The Seg-9 nt sequences were divided into
eastern and western groups (Fig. 5— supplementary data). Seg-9 of
the eastern BTV isolates is 1052 bp, encoding a protein 330 aa in
length, while Seg-9 from the western lineage is 1049 bp (329 aa)
(Table 1). The upstream NCR is 14–15 bp (W–E), while the down-
stream NCR is 44 bp. Seg-9 of NET2006/04 belongs to the western
group and is closely related to the Corsican isolate of BTV-2 (Ac. No.
AY124373 — 97.1% identity) and the South African BTV-2 vaccine
strain (Ac. No. AF530066 — 94.2% identity), but is more distantlyences of Seg-6 from European strains of BTV serotype 1, 2, 4, 8, 9 and 16.
Fig. 4. Neighbour-joining tree showing relationships between nucleotide sequences of Seg-7 from different BTV serotypes.
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BTV-9-BOS2002/02 and BTV-16-TUR2000/01 (76.6% identity). Overall
Seg-9 showed N75.8% nt similarity across the eastern and western
strains of BTV.
Genome segment 10 of NET2006/04 is 822 bp long, coding for the
small non-structural proteins NS3 (229 aa) andNS3a (216 aa) (Table 1).Fig. 5. Neighbour-joining tree showing relationships between nucleotide sequences of
Seg-8 from BTV isolates from Europe and around the world.The upstream and downstream NCRs are 19 and 113 bp long respec-
tively. Seg-10 which is N82% conserved, across all of the isolates
compared, can be divided into four groups, two from eastern and two
fromwestern origins. Seg-10 from European isolates of BTV-1, 9 and 16
cluster together in eastern group 1 (equivalent to clade A1 of Seg-10—
reported by Balasuriya et al., 2008), while the European isolates of
BTV-2 and 4, and South African reference strain of type 1 clusterwithin
western group 2 (equivalent to sub-clade A3 within clade A2 —
Balasuriya et al., 2008) (Fig. 6). Seg-10 of the South African vaccine
strains of BTV-1, 2, 3, and 4, cluster withinwestern group 1 (equivalent
to clade B2 — Balasuriya et al., 2008). NET2006/04, is included in this
group andwasmost closely related to the vaccine strains of BTV-2 (Ac.
No. AF481094— 96.2% identity), BTV-4 (Ac. No. AF512908 — 93.8%
identity), BTV-3 (Ac. No. AF512918 — 92.3% identity), and BTV-1 (Ac.
No. AF512910— 92.2% identity). Butwasmore distantly related (b82.9%
identity) to the European BTV isolates in eastern group 1 or western
group 2.
Conserved terminal sequences and stop codons
The upstream and downstream terminal hexanucleotides (Mertens
et al., 2007e) are maintained for the majority of the BTV genome
segments included in these analyses (Table 1). However, a substitution
of C to A was detected at the sixth position from the 3′ end of Seg-1
from NET2006/04. Another substitution of T for A was detected at the
sixth position from the downstream end of Seg-9 from NET2006/06
and six of the other western viruses (out of 41 strains analysed).
The stop codon of Seg-1 is …UGA…, while Seg-4 and 9 use UAA,
and Seg- 3, 5, 7 and 8 use UAG. The stop codon of Seg-6 is conserved as
UGA across isolates of all 24 BTV serotypes. In contrast stop codons are
not conserved in Seg-2 between different BTV types, and include …
UGA…,…UAG… and…UAA… (Maan et al., 2007a), although all of the
BTV-8 strains use …UAG….. Seg-10 of NET2006/04, BTV-1 and BTV-2
vaccine strains, (all of which are in western group 2) use…UGA… The
other ﬁeld strains and the BTV-8 vaccine strain (that are included in
Fig. 6. Neighbour-joining tree showing relationships between nucleotide sequences of Seg-10 from BTV isolates from Europe and around the world.
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use …UAA….
Discussion
In August 2006, sheep in the Maastricht region of the Netherlands
started showing severe clinical signs that were typical of ‘bluetongue’
disease. Blood samples were sent to the Central Institute for Animal
Disease Control (CIDC) at Lelystad in the Netherlands, where BTV-
speciﬁc antibodies were detected by ELISA, and the presence of BTV
was conﬁrmed by RT-PCR targeting Seg-10 (Toussaint et al., 2007;
Vandenbussche et al., in press). This was the ﬁrst time that an outbreak
of bluetongue had ever been identiﬁed in northern Europe. Further
blood samples were sent to the CRL at IAH Pirbright in the UK, where
competition ELISA conﬁrmed that these samples were positive for
BTV-speciﬁc antibodies (Batten et al., 2008; Vandenbussche et al., in
press). A C. sonorensis cell line (KC cells) and BHK cells were used to
isolate virus (IAH reference collection isolate number NET2006/04),
which was subsequently identiﬁed as BTV by conventional and real-
time RT-PCR assays targeting Seg-7 and Seg-1 respectively (Anthony
et al., 2007; Shaw et al., 2007).
We report the ﬁrst identiﬁcation of the northern European strain
(NET2006/04) as BTV-8, by conventional RT-PCR assays using serotype-
speciﬁc primers targeting Seg-2 (Mertens et al., 2007f, g), togetherwith
a complete nucleotide sequence for the genome of NET2006/04. Phy-
logenetic analyses showed that all of the genome segments of this
isolate contain signiﬁcant numbers of nucleotide changes, compared to
segments (where published) of the BTV vaccine or ﬁeld strains that
were used, or already circulating in southern Europe. This supports
serological evidence that NET2006/04 represents the novel introduc-
tion of an exotic BTV strain/serotype into Europe, although details of its
entry route to the region remain unknown. These analyses indicate that
NET2006/04 is not derived from the BTV-8 vaccine strain, which was
used as part of the South African ‘Group B’ multivalent live attenuated
vaccine (containing BTV-3, 8, 9, 10 and 11) in Bulgaria during 2000(Panagiotatos, 2004; Savini et al., in press). However, there was some
serological evidence indicating BTV-8 infections of sentinel animals in
Bulgaria during 2006, even though attempts to isolate or detect the
virus by RT-PCR were unsuccessful (OIE, 2006b).
The situation that has occurred in Europe since 1998 is unique,
with the introduction of multiple ﬁeld strains fromwestern (BTV-1, 2,
4, 8) and eastern (BTV-1, 9, 16) lineages. Live attenuated monovalent
‘vaccine’ strains of BTV-2, 4, 8, 9 (western group) and BTV-16 (eastern
group) have also been used in the Mediterranean region, in attempts
to minimise virus circulation. The release of these vaccine strains,
some of which (including BTV-2 and 16) have persisted in the ﬁeld,
has added further genetic diversity generating an unprecedented mix
of ﬁeld and vaccine strain viruses, from both eastern and western
lineages within southern Europe. This has provided multiple oppor-
tunities for the exchange/reassortment of genome segments between
different strains, as already reported between strains of BTV-2 and 16
(Batten et al., in press; Monaco et al., 2005).
Genome segments from European and (selected) other BTV strains
from around the world were compared. Variations were detected in
each of the segments that correlate with their geographic origins,
dividing them into eastern and western topotypes/groups (Fig. 6 —
Supplementary data). All of the genome segments of NET2006/04
grouped with other ‘western’ viruses. The east/west grouping appears
to be a dominant characteristic of the Orbivirus phylogeny, supporting
observations previously made for Seg-3 of BTV and EHDV (Cheney
et al., 1995; Gould and Pritchard 1991; Pritchard et al., 1995).
The BTV outer capsid proteins VP2 and to a lesser extent VP5 (en-
coded by genome segments 2 and 6) interact with neutralising anti-
bodies and are the most variable of the BTV proteins/genome segments
(Fig. 6 — Supplementary data) (Cowley and Gorman 1989; Huismans
et al., 1987; Maan et al., 2007a; Singh et al., 2004). Sequencing studies
and phylogenetic comparisons of Seg-2 from different BTV isolates can
beused to identify the24BTV serotypes (Maanet al., 2007a) andprovide
a basis for serotype-speciﬁc RT-PCRassays (Mertens et al., 2007f, 2007g).
These methods were used successfully to identify different BTV types
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et al., 2000, 2007; Mertens et al., 2007f,g; Potgieter et al., 2005;
Zientara et al., 2006). In the studies described here, only Seg-2 and Seg-
6 showed variations that correlate with virus serotype, conﬁrming the
initial identiﬁcation (by RT-PCR) of NET2006/04 as BTV-8. BTV-8 has
previously been isolated from Kenya, Nigeria, South Africa, South and
Central America (Mo et al.,1994), and India (Daniels et al., 2004; Prasad
et al., in press). Seg-2 of NET2006/04wasmost closely related to BTV-8
from Nigeria in 1982 (NIG1982/07), indicating that the northern
European strain originated in sub-Saharan Africa. It also showed a
close relationship in the more conserved genome segments with the
Corsican strains of BTV-2 or BTV-4 (2000 onwards), which were also
recently derived from an African lineage.
Seg-3 showed up to 99.8% nt similarity between the BTV-2 strains
fromCorsica andmainland Italy, with BTV-4 strains fromMorocco and
Spain indicating that (despite belonging to different serotypes) these
strains all share Seg-3 from a recent common ancestor, providing
evidence of genome segment exchange/reassortment. Despite also
belonging to different serotypes, Seg-5 from the 1999 strain of BTV-16
from Greece (GRE1999/13) is also very similar to BTV-9 from Bulgaria
(99.9%) indicating that they have also been involved in a recent
reassortment event.
The clear separation of the majority of the BTV genome segments
into eastern and western groups indicates that the viruses in these
different regions have been separated and have acquired point muta-
tions over a relatively long period of time, with little or no mixing or
exchange between them. The existence of distinct eastern and west-
ern topotypes of Seg-2 and Seg-6, within individual BTV serotypes,
also suggests that these different ‘types’ diverged and became gene-
tically distinct as an initial step. Individual strains or lineages of each
type subsequently became separated (geographically), allowing them
to accumulate point mutations, and generating distinct topotypes
within the each serotype.
Genome Seg-7 and Seg-10 also showed major variations that do
not simply reﬂect the geographic origins of the virus isolate (Fig. 6 —
Supplementary data). Seg-10 is the fourth most variable segment of
the virus strains compared here, which separated into 4 distinct
groups, two eastern and two western (although one of the eastern
groups is represented by only a single strain of BTV-15 from China —
Nikolakaki et al., 2005). The signiﬁcance of these variations in Seg-10
remains uncertain, however theymay relate to the role of NS3/NS3a in
the release of progeny virus particles from the host cell (Hyatt et al.,
1989). In a recent extensive study of sequence variations in BTV Seg-
10, Balasuriya et al. (2008) identiﬁed twomain groups (A and B) with a
number of sub-clades. Some of these groups (clades A4, B1 and B3)
containing viruses from the Americas, and the BTV-9 vaccine strain,
were not included in the study presented here. However, sub-clades
A1, A2–A3 and B2 appear to be equivalent to eastern group1, western
group 2 and western group 1 respectively. The Chinese isolate of BTV-
15, which forms the eastern group 2 identiﬁed here, was not included
in the study by Balasuriya et al. (2008), although it appears likely that
it would form a further distinct clade or sub-clade.
Wilson et al. (2000) compared BTV Seg-7 sequences, primarily
from western isolates, showing several distinct clades that appear to
form three distinct groups. These authors also identiﬁed two eastern
strains that did not ﬁt within these western groups. The sequences
compared here indicate that Seg-7 is the third most variable of the
BTV genome segments (Fig. 6— Supplementary data). Seg-7 separated
into six distinct groups, three of which ﬁt with the groups described
by Wilson et al. (2000), containing mainly western viruses (with the
exception of BTV-12 from China, which grouped along with NET2006/
04 within western group 1). The three other groups all contained
eastern viruses. However, unlike Seg-7, Seg-10 of BTV-12 from China
groups with other eastern strains, suggesting that this virus acquired a
‘western’ Seg-7 by reassortment, possibly from an exotic strain of the
virus introduced into the region.The data presented here provide the ﬁrst complete sequence (seg-
ments 1–10) of the northern European strain of BTV-8. Although
subsequent data for other isolates from the European outbreak in
2006 to 2008 have detected small numbers of nucleotide changes in
several genome segments, they conﬁrm that the strains were all
closely related, representing a single virus lineage. Comparisons of
NET2006/04 with the sequences of subsequent isolates will be used to
track virus movements at different stages (years) of the outbreak.
These comparisons will also help to identify any subsequent reas-
sortment events involving this virus strain, and help to identify other
related strains from different locations.
Materials and methods
Virus isolates, virus isolation and propagation in cell culture
Virus isolates from the reference collection at IAH Pirbright are
referred to by their reference collection number, with the generic
format ‘three letter country code’ year of isolation/isolate number for
that year. Table 1 (supplementary data) gives details concerning the
country of origin, year of isolation and EMBL/GenBank accession
numbers for the isolates used in this study.
Blood samples (containing EDTA) taken frompyrexic animals at the
start of the 2006 Netherlands outbreak of BT, were provided by Dr.
Eugène van Rooij — CIDC-Lelystad, Netherlands. A 3.0 ml aliquot of
each EDTA blood sample was washed three times with 10 ml of sterile
phosphate-buffered saline (PBS). The red blood cells (RBC) were cen-
trifuged at 3000 ×g for 5 min at 4 °C and the supernatant discarded.
After the ﬁnal wash, the RBCs were resuspended in 3.0 ml of PBS. RNA
was extracted from 1.0 ml of the washed RBC for RT-PCR. 1.0 ml of the
washed RBC was injected into embryonated chicken eggs. The har-
vestedmaterial was designated BTV8-E1. The remainder of thewashed
RBC were used for virus isolation in C. sonorensis (KC) cells (originally
provided by colleagues at the USDA lab in Laramie,Wyoming). At 7 dpi
KC culture supernatants (inoculated with sample number A83/06-6,
from ‘sheep number 6’) was used to infect BHK-21 cells. The resulting
virus isolate (NET2006/04–KC1/BHK1) was used for sequencing
studies. Further details concerning the origins and passage history of
individual virus isolates can be found at Mertens et al. (2007d).
Isolation and puriﬁcation of nucleic acids
RNA was extracted from cell-free supernatants, or EDTA treated
blood samples, using the QIAamp Viral RNA Mini Kit (QIAGEN) as per
manufacturer's protocol, The RNA required for synthesis of full-length
cDNA copies of genome segments, for sequencing (Attoui et al., 2000;
Maan et al., 2007a,b), was puriﬁed from infected monolayers using
Trizol® (Invitrogen), in accordance with manufacturer's instructions.
Identiﬁcation and typing of the Netherland isolate (NET2006/04)
RNA from cell-free supernatants or EDTA treated blood samples,
were used in RT-PCR assays. Serogroup-speciﬁc real-time RT-PCR as-
says targeting Seg-1 were carried out as described by Shaw et al.
(2007). Conventional serogroup-speciﬁc RT-PCR assays targeting Seg-7
(Anthony et al., 2007), and serotype-speciﬁc assays (targeting Seg-2:
Mertens et al., 2007f,g), were performed using a single tube RT-PCR
method following the “One-Step RT-PCR kit” protocol (Qiagen, Courta-
boeuf, France). Five microlitres of each RT-PCR was analyzed by elec-
trophoresis on a 1% agarose gel.
Full length cDNA synthesis and ampliﬁcation by PCR
Puriﬁed viral dsRNA was used for cDNA synthesis as described by
Maan et al. (2007a,b). Brieﬂy, ~400 ng of dsRNAs were ligated to a
single-stranded anchor-primer using T4 RNA ligase (NEB) at 4 °C for
317S. Maan et al. / Virology 377 (2008) 308–31812 h. The oligo-ligated dsRNAs of BTV-8 isolate (NET2006/04) were
converted to full length cDNAs using the AMV reverse transcription
system (Promega) at 37 °C for 1 h. The DNA segments were then
puriﬁed by agarose gel electrophoresis (AGE) and recovered from the
gel as four pools: large genome segments (Seg-1, tube 1; Seg-2 and
Seg-3, tube 2); medium (Seg-4 to 6, tube 3) and small (Seg-7 to10, tube
4). PCRs were performed on the cDNAs using the ‘Triple Master PCR
system’ (Eppendorf) with a single primer complementary to the
anchor-primer: denaturing at 95 °C for 30 s, then annealing and
extension at 68 °C for 3 min, for 30 cycles.
Sequence determination of genome segments
Full length cDNA amplicons were generated (in four separate
reactions: tubes 1 to 4) for all 10 genome segments of NET2006/04.
Each cDNA was puriﬁed by 1% TAE agarose gel electrophoresis (AGE),
excised from the gel and puriﬁed using a GFX™ PCR DNA and gel band
puriﬁcation kit' (Amersham Pharmacia Biotech, Inc) as per the manu-
facturer's instructions. The puriﬁed cDNA of each amplicon was used
for direct sequencing, in both directions, using BTV-speciﬁc ‘phased-
primers’ (Maan et al., 2007b) and ‘Cycle Sequencing Ready Reaction’
kit (CEQ DTCS Beckman Coulter) on a Beckman Capillary Sequencer.
Internal forward and reverse primers were designed from the result-
ing terminal sequence data, generating full-length contiguous se-
quences of all 10 genome segments.
Sequence analysis
Consensus sequences from each segment were assembled and
analyzed using SeqMan Software (DNAStar Inc.). All sequence align-
mentswere performedwith the CLUSTALWsoftware (Thompson et al.,
1994). Phylogenetic treeswere constructed by neighbour-joining using
distance matrices generated by the p-distance determination algo-
rithm in MEGA 3 (2000 bootstrap replicates) (Kumar et al., 2004).
Sequence relatedness is reported as percentage identity. The sequences
obtained for each genome segment has been submitted to EMBL and
the accessionnumbers obtained areAM498051 toAM498060 (Table 1).
For accession numbers of previously published sequences see:Mertens
et al. (2007a) and Table 1 — supplementary data.
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